|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012138734A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
RU2014111055A
(ru)
|
2011-08-22 |
2015-09-27 |
Мерк Шарп И Доум Корп. |
2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
|
|
JP6251249B2
(ja)
*
|
2012-05-24 |
2017-12-20 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｂａｃｅ１阻害薬としての５−アミノ［１，４］チアジン類
|
|
WO2014059185A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Amgen Inc. |
Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
|
US9447085B2
(en)
|
2012-12-14 |
2016-09-20 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use
|
|
CN104870000A
(zh)
*
|
2012-12-20 |
2015-08-26 |
默沙东公司 |
作为bace抑制剂的c5,c6氧杂环稠合的亚胺基噻嗪二氧化物化合物,组合物及其用途
|
|
US9580396B2
(en)
|
2012-12-21 |
2017-02-28 |
Merck Sharp & Dohme Corp. |
C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
AU2014223334C1
(en)
|
2013-03-01 |
2018-10-18 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
EP2964644B1
(en)
|
2013-03-08 |
2018-12-26 |
Amgen, Inc. |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2014150340A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiadiazine compounds as bace inhibitors, compositions, and their use
|
|
US9422255B2
(en)
|
2013-03-15 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use
|
|
US9453034B2
(en)
*
|
2013-03-15 |
2016-09-27 |
Merck Sharp & Dohme Corp. |
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
|
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
|
EP3083575B1
(en)
|
2013-12-18 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
US9745324B2
(en)
|
2013-12-18 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
|
|
EP2918171A1
(en)
*
|
2014-03-14 |
2015-09-16 |
University of Vienna |
Novel plant growth regulators and their use in modulating organ number
|
|
JP6111002B1
(ja)
|
2014-04-10 |
2017-04-05 |
ファイザー・インク |
２−アミノ−６−メチル−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル−１，３−チアゾール−４−イルアミド
|
|
WO2015187437A1
(en)
|
2014-06-02 |
2015-12-10 |
Merck Sharp & Dohme Corp. |
C2-carbocyclic iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
CN106661053B
(zh)
|
2014-07-25 |
2019-07-12 |
豪夫迈·罗氏有限公司 |
吡啶基-三氮杂二环类化合物
|
|
EP3191447B1
(en)
|
2014-09-12 |
2019-05-01 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
|
|
WO2016118404A1
(en)
|
2015-01-20 |
2016-07-28 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as bace inhibitors, compositions, and their use
|
|
CA2979113A1
(en)
*
|
2015-03-20 |
2016-09-29 |
F. Hoffmann-La Roche Ag |
Bace1 inhibitors
|
|
JP6765681B2
(ja)
*
|
2015-04-21 |
2020-10-07 |
オールジェネシス バイオセラピューティクス インコーポレイテッド |
Ｂａｃｅ１阻害剤としての化合物およびそれらの使用
|
|
US10246429B2
(en)
|
2015-08-06 |
2019-04-02 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
US20170107216A1
(en)
|
2015-10-19 |
2017-04-20 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
MD3377488T2
(ro)
|
2015-11-19 |
2023-02-28 |
Incyte Corp |
Compuși heterociclici ca imunomodulatori
|
|
WO2017095759A1
(en)
|
2015-12-04 |
2017-06-08 |
Merck Sharp & Dohme Corp. |
C5-c6-carbocyclic fused iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
|
CA3009474A1
(en)
|
2015-12-22 |
2017-06-29 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SG11201811414TA
(en)
|
2016-06-20 |
2019-01-30 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
MX387729B
(es)
*
|
2016-12-15 |
2025-03-18 |
Amgen Inc |
Derivados de dióxido de 1,4-tiazina y dióxido 1,2,4-tiadiazina como inhibidores de beta-secretasa y métodos de uso.
|
|
MX386618B
(es)
|
2016-12-15 |
2025-03-19 |
Amgen Inc |
Derivados de tiazina condensados con ciclopropilo como inhibidores de beta-secretasa y métodos de uso.
|
|
AU2017376445B2
(en)
|
2016-12-15 |
2021-09-30 |
Amgen Inc. |
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX388697B
(es)
|
2016-12-15 |
2025-03-20 |
Amgen Inc |
Derivados de tiazina como inhibidores de beta-secretasa y metodos de uso.
|
|
AU2017376441B2
(en)
|
2016-12-15 |
2021-10-14 |
Amgen Inc. |
Oxazine derivatives as beta-secretase inhibitors and methods of use
|
|
US10308644B2
(en)
|
2016-12-22 |
2019-06-04 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
EP4223369A1
(en)
|
2016-12-22 |
2023-08-09 |
Incyte Corporation |
Immunomodulator compounds and methods of use
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
AU2018346597B2
(en)
|
2017-10-06 |
2023-07-13 |
Forma Therapeutics, Inc. |
Inhibiting Ubiquitin Specific Peptidase 30
|
|
EP3728234B1
(en)
*
|
2017-12-21 |
2025-05-14 |
F. Hoffmann-La Roche AG |
Radiolabeled compounds
|
|
CN112135825A
(zh)
|
2018-03-13 |
2020-12-25 |
夏尔人类遗传性治疗公司 |
血浆激肽释放酶抑制剂及其用途
|
|
SMT202300065T1
(it)
|
2018-03-30 |
2023-05-12 |
Incyte Corp |
Composti eterociclici come immunomodulatori
|
|
BR112020021728A2
(pt)
|
2018-04-27 |
2021-01-26 |
Shionogi & Co., Ltd. |
derivados de tetra-hidropiranooxazina tendo atividade inibitória de bace1 seletiva
|
|
CN112752756B
(zh)
|
2018-05-11 |
2024-06-25 |
因赛特公司 |
作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
|
|
CN110467611B
(zh)
*
|
2018-05-11 |
2022-09-27 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
IL278291B2
(en)
|
2018-05-17 |
2023-10-01 |
Forma Therapeutics Inc |
Condensed bicyclic compounds are useful as ubiquitin-specific peptidase 30 inhibitors
|
|
CN108997328B
(zh)
*
|
2018-09-06 |
2021-06-08 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
CN109180671A
(zh)
*
|
2018-09-21 |
2019-01-11 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
CN109180672A
(zh)
*
|
2018-09-29 |
2019-01-11 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
EP4218934B1
(en)
|
2018-10-05 |
2025-06-18 |
Forma Therapeutics, Inc. |
Inhibiting ubiquitin-specific protease 30 (usp30)
|
|
CN109796447B
(zh)
*
|
2019-01-07 |
2020-03-13 |
广东东阳光药业有限公司 |
亚氨基噻二嗪二氧化物衍生物及其用途
|
|
TW202115059A
(zh)
|
2019-08-09 |
2021-04-16 |
美商英塞特公司 |
Ｐｄ—１／ｐｄ—ｌ１抑制劑之鹽
|
|
EP4017850A1
(en)
*
|
2019-08-21 |
2022-06-29 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
CN114728962B
(zh)
|
2019-09-18 |
2025-09-19 |
武田药品工业有限公司 |
血浆激肽释放酶抑制剂及其用途
|
|
WO2021055589A1
(en)
|
2019-09-18 |
2021-03-25 |
Shire Human Genetic Therapies, Inc. |
Heteroaryl plasma kallikrein inhibitors
|
|
JP7559059B2
(ja)
|
2019-09-30 |
2024-10-01 |
インサイト・コーポレイション |
免疫調節剤としてのピリド［３，２－ｄ］ピリミジン化合物
|
|
EP4058461A1
(en)
|
2019-11-11 |
2022-09-21 |
Incyte Corporation |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
|
WO2022089598A1
(zh)
*
|
2020-10-30 |
2022-05-05 |
杭州拉林智能科技有限公司 |
黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
|
IL302590A
(en)
|
2020-11-06 |
2023-07-01 |
Incyte Corp |
Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
|
|
CN113073098B
(zh)
*
|
2021-02-20 |
2024-08-20 |
北京理工大学 |
抑制BACE1基因表达的siRNA修饰物及其应用
|
|
CN113105318B
(zh)
*
|
2021-02-23 |
2022-05-20 |
中山大学 |
一种2,2-二氟环丁烷-1-羧酸的制备方法及应用
|
|
CA3256688A1
(en)
|
2022-04-28 |
2025-04-22 |
Daiichi Sankyo Company, Limited |
BENZOTRIAZOLE COMPOUND
|
|
CN119080651B
(zh)
*
|
2024-10-31 |
2025-02-07 |
汕头大学 |
一种可见光协同钴催化制备烯丙基砜类化合物的方法
|